Piramal Pharma Solutions implemented a robust action plan to address evolving regulatory requirements pertaining to nitrosamine impurities. Through comprehensive risk assessments, confirmatory testing, and control strategies, the Company is ensuring…
Piramal Pharma Solutions implemented a robust action plan to address evolving regulatory requirements pertaining to nitrosamine impurities. Through comprehensive risk assessments, confirmatory testing, and control strategies, the Company is ensuring…
, /PRNewswire/ — mAIbe et LenioBio ont le plaisir d’annoncer une nouvelle collaboration stratégique visant à accélérer la découverte et la validation expérimentale d’anticorps monoclonaux de nouvelle génération. En combinant…
, /PRNewswire/ — CaliberMRI, an industry leader in standardizing Magnetic Resonance Imaging (MRI), announced the release of a new quantitative MRI phantom compatible with the Medium ACR phantom. CaliberMRI’s qDisc…
, /PRNewswire/ — Cure SMA, the leading nonprofit organization dedicated to supporting those impacted by spinal muscular atrophy (SMA), welcomes the FDA approval of Itvisma™ (onasemnogene abeparvovec-brve) by Novartis for…
, /PRNewswire/ — TCI Biotech (TCI Co., Ltd.), a global CDMO+ specializing in functional foods, nutraceuticals, and beauty supplementation, today announced the launch of the TCI Advanced Performance Nutrition Research…
JOTO PR Disruptors™ has signed First Ascent Biomedical to amplify its AI-driven precision medicine technology transforming cancer treatment. , /PRNewswire/ — In the race against cancer, where every day counts,…
, /PRNewswire/ — Vascular Perfusion Solutions, Inc. (VPS) announced a collaboration with the Wyss Institute at Harvard University, the University of Colorado, and the University of Wyoming under the Advanced…
, /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Dean Schorno, the company’s chief financial officer, will…
, /PRNewswire/ — mAIbe and LenioBio are pleased to announce a new strategic collaboration aimed at accelerating the discovery and experimental validation of next-generation monoclonal antibodies. By combining mAIbe’s AI-driven…